申请人:Hoechst Aktienegesellschaft
公开号:US05814627A1
公开(公告)日:1998-09-29
A compound having the formula (I), a physiologically tolerable salt of the compound having the formula (I) and/or a steroisomeric form of the compound having the formula (I), in which one residue R.sup.1 or R.sup.2 stands for the formula (II), are suitable for preparing medicaments for the therapy of inflammations, asthma, rheumatoid diseases and auto-immune diseases.
具有化学式(I)的化合物,具有化学式(I)的生理耐受盐和/或具有化学式(I)的立体异构体形式,其中一个残基R.sup.1或R.sup.2代表化学式(II),适用于制备用于治疗炎症、哮喘、类风湿病和自身免疫疾病的药物。